BridgeMD
New treatment option for Chronic Disease
Official title Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases
ClinicalTrials.gov ID: NCT07589673
What this study is testing
- What it's testing
- This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases. Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- for Nurse:
- Registered nurses currently providing direct patient care in participating general hospitals
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to use a computer, tablet, or smartphone to access the online program
You likely can't join if
- for Nurse:
- Not currently engaged in direct patient care
- Unable to clearly express willingness to participate
- Unable to complete the educational program or questionnaires because of technical or language limitations Inclusion Criteria for Patients:
- Adults aged 19 years or older living in the community
- Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia...
See the full eligibility criteria
- for Nurse:
- Registered nurses currently providing direct patient care in participating general hospitals
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to use a computer, tablet, or smartphone to access the online program
- for Nurse:
- Not currently engaged in direct patient care
- Unable to clearly express willingness to participate
- Unable to complete the educational program or questionnaires because of technical or language limitations Inclusion Criteria for Patients:
- Adults aged 19 years or older living in the community
- Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease...
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to read and respond to survey questions
- Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Patients:
- Cognitive impairment or communication problems that make participation difficult
- Unable to complete the educational program or questionnaires because of technical or language limitations
The study team makes the final eligibility decision.
Where it's taking place
- Daejeon, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Daejeon, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.